Welcome to Dermaheal

Go to the main menu Skip to content

CAREGEN

Caregen is a global leader of research and marketing of
Biomimetic Peptides and Growth Factors.

Caregen is not only the world's first company which has registered Growth Factors in PCPC (Personal Care Products Council, formerly CTFA), but also possesses various Biomimetic Peptide patents all around the world.

Our advanced R&D in biotechnology industry has led us to patented active ingredients with an excellent reputation in the cosmetic industry for many years.

Dermaheal was launched in 2004 and the name 'Dermaheal' is a compound word using 'Dermis' and 'Heal' with the concept of taking care of our skin with innovative active ingredients. Dermaheal has been attracting customers all over 120 countries and keeping up with technological innovation to make our products more accessible and affordable to our customers.
History
2016
- 03 DR.CYJ Hair Filler acquired CE
2015
- 12 2nd Manufacturing(CGMP) OPEN
- 12 PROSTROLANE acquired CE
- 12 KITA awarded to Caregen
- 11 Caregen was listed on KOSDAQ on 17th Nov
- 02 Food Manufacturing Processing Business registration
2014
- 06 Received CE marking for soft filler, REVOFIL, AQUASHINE
2013
- 02 17 Biomimetic peptides applied in PCPC
2012
- 11 1 Biomimetic peptide registered in PCPC
- 05 5 Biomimetic peptides registered in PCPC
- 04 1 Biomimetic peptide registered in PCPC
- 02 9 Biomimetic Peptides registered in PCPC, Relocation of Head office, R&D center and
  manufacturing facility for expansion (Current address)
- 01 REVOFIL launched
2011
- 11 Acquired CE 1023 of REVOFIL
- 02 Acquired CE 1023 of Dermaheal SB/LL
2010
- 12 10 Biomimetic peptides applied in PCPC
- 04 7 Biomimetic peptides registered in PCPC
2009
- 09 RENOKIN launched
- 08 Acquired CE 1023 Dermaheal HSR/SR/HL
- 07 Acquired ISO 13485
- 02 8 Biomimetic peptides registered in CTFA
2008
- 12 Awarded 100 Top Patent by Small & Medium Business Administration
- 10 3 Biomimetic peptides registered in CTFA
2007
- 11 9 Biomimetic peptides registered in CTFA
- 04 3 Biomimetic peptides registered in CTFA
2006
- 07 9 Biomimetic peptides registered in CTFA
- 04 4 Growth Factors registered in CTFA Dermaheal launched
2005
- 11 Acquired ISO 9001 & 14001
- 10 3 Growth Factors and 6 Biomimetic peptides registered in CTFA
- 07 Developed Rejuline & Prohairin-ß4 Peptides
2004
- 08 Designated a Promising Export Firm by Small & Medium Business Administration
- 07 11 Growth Factors registered in CTFA
2003
- 06 Acquired Certification of NT Venture Biotech Company
2002
- 03 Started research of Biomimetic Peptide
- 01 Founded R&D Center and relocation of Head Office
2001
- 08 Established Caregen Co., Ltd.
Business Area

RAW MATERIALS FOR COSMECEUTICALS

Caregen has developed different types of growth factors such as CG-EGF, CG-IGF1, CG-aFGF,
CG-VEGF, CG-TRX, CG-IL10, etc. Besides growth factors, biomimetic peptides are becoming the
fastest growing and the most appreciated materials in cosmeceutical and pharmaceutical industries.

Caregen biomimetic peptides, such as Rejuline, CG-Purilux, CG-Dermaheal, CG-Keramin2,
Prohairin-ß4, CG-TGP2, CG-EDP3 and CG-IDP group have almost equivalent activities compared to
their intact growth factors.

OEM / ODM

Our expertise and experience in biotechnology give us capability of developing various cosmeceutical products with high quality. From raw materials to finished products, Caregen provides what customer needs and wants.

COSMECEUTICALS

'DERMAHEAL' is a brand to provide high quality cosmeceutical products which contain Caregen's
state of the art growth factors and biomimetic peptides.
Dermaheal products take care of Anti-aging, Anti-pigmentation, Anti-hair loss,
Anti-inflammation and other skin troubles in homecare and professional lines.

RENOKIN

'RENOKIN' is a brand established as advanced hair revitalizing product line
with unique peptide complex.

REVOFIL

'REVOFIL' is a very first kind, the most revolutionary dermal filler.
It is an ideal solution for everyone and remarkably designed for face
contour improvements. For more information,
please check http://www.revofil.com
Platform Technology

GROWTH FACTORS

Caregen has committed to the R&D of growth factors, which have been produced by the transformed
bacterial system. Developing high quality growth factors and mass production skill are key knowhows
of Caregen technology.

BIOMIMETIC PEPTIDES

Caregen has been developing a plenty of biomimetic peptides and successfully commercialized in
cosmeceuticals. Caregen is a leading company in the field of developing biomimetic peptides for
cosmeceutical and pharmaceutical applications.

Caregen is pursuing expansion of its application to pharmaceuticals, functional foods and therapeutics.

ENHANCING SKIN PENETRATION

Caregen has been developed double-layered capsulation technology
as a transdermal delivery system.
Every active ingredients are capsulated by double-layered
capsulation technology for better skin penetration.

STEM CELL RESEARCH

Caregen has focused on the research of skin stem cell
proliferation and differentiation for cosmeceutical application.

Growth Factors Biomimetic Peptides
Growth Factors

WHAT IS GROWTH FACTOR

Growth factors are proteins that bind to their own receptors on cell surface with the primary result of activating cell proliferation and/or differentiation.
Not only as strong mitogens, growth factors are regulating the expressions of ECMs (Extra Cellular Matrix) like collagen, elastin and laminin etc.

SUPERIORITY OF GROWTH FACTORS
- - Competitive price based on mass production technology
- - High efficacy and stability by double-layered capsulation technology
- - High purity by sophisticated production facility and technical superiority Biomimetic Peptides Technology 2
Biomimetic Peptides

WHAT IS BIOMIMETIC PEPTIDE

Caregen has developed biomimetic peptides since 2002 based on broad growth factor studies. Caregen's commercialized peptides are synthetic agonists of naturally-occurring growth factors and completely mimic the action of the parental molecules. Those biomimetic peptides can provide clinical benefits similar to recombinant growth factors, reduced costs, and greater chemical stability.

COMPARATIVE ADVANTAGES OF BIOMIMETIC PEPTIDES
- - Sustainable new biomimetic peptides development
- - Competitive price based on mass production technology
- - High efficacy and stability by double-layered capsulation technology
- - High purity by sophisticated production skill based on technical superiority